Tuberculosis researcher Christopher Vinnard of Rutgers’ Public Health Research Institute is developing a urine test that can pinpoint—easily and resourcefully—the effectiveness of patients’ TB treatment dosages. This new test would be more accessible to clinicians in low-income countries.
An international team that includes Rutgers scientists has made significant progress in developing a urine diagnostic test that can quickly, easily and inexpensively identify tuberculosis infection in people also infected with HIV. The findings were announced at the September 26, 2018, United Nations meeting on TB.
